Dusigitumab

• Target :

  IGF-1R

• Related Pathways :

  Tyrosine Kinase/Adaptors

• Purity :

  0.965

• Bioactivity :

  Dusigitumab (MEDI573) is a fully humanised monoclonal antibody targeting IGF1/IGF2, inhibiting IGF1/IGF2-induced IGF-1R phosphorylation with an IC?? of 0.97/0.2 µg/mL, suitable for cancer research.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1204390-13-5